MYCN and neuroblastoma: With neuroblastoma-targeted antigens incorporating multiple costimulatory molecules and a suicide gene-inducible caspase9 (iCasp9), the success of fourth-CAR T cells against MYCN amplification in neuroblastomas has been reported [53].